Sun L M, Wang C J, Huang C C, Leung S W, Chen H C, Fang F M, Huang E Y, Lee S P
Department of Radiation Oncology, Chang Gung Memorial Hospital, 123, Ta-Pei Rd., Niao Sung Hsiang, Kaohsiung Hsien, Taiwan, ROC.
Radiother Oncol. 2000 Nov;57(2):175-81. doi: 10.1016/s0167-8140(00)00228-0.
This study evaluates the treatment results of patients with dermatofibrosarcoma protuberans.
Between August 1987 and July 1998, 35 consecutive patients with pathologically proved dermatofibrosarcoma protuberans received surgery with or without radiation therapy. Their treatment results were analyzed retrospectively.
The patient ages ranged from 5 to 67 years (median 37 years). There were 24 males and 11 females. The anatomic sites of tumor were: trunk in 21, extremity in eight, and head and neck region in six. The maximal dimension of tumor ranged from 1.5 to 25 cm. Surgery techniques included local excision and wide excision with or without graft or flap. Adjuvant radiation therapy was given to 11 patients, with a dose ranging from 46 to 68 Gy (one pre-operative, ten post-operative). At a median follow-up of 50 months (range 11-131 months), there were 11 patients (nine patients without radiation therapy) who developed local failure. Salvage therapy (excision with or without radiation therapy) was given to all of them, and ten achieved disease control. Some patients had treatment-related moderate cosmetic or functional problems.
Dermatofibrosarcoma protuberans is a malignancy of a high cure rate, and adjuvant radiation therapy can reliably decrease the local recurrence rate and prevent mutilation and functional deficit caused by repeated surgery.
本研究评估隆突性皮肤纤维肉瘤患者的治疗结果。
1987年8月至1998年7月期间,35例经病理证实的隆突性皮肤纤维肉瘤患者接受了手术治疗,部分患者还接受了放射治疗。对他们的治疗结果进行回顾性分析。
患者年龄在5岁至67岁之间(中位年龄37岁)。男性24例,女性11例。肿瘤的解剖部位为:躯干21例,四肢8例,头颈部6例。肿瘤最大直径在1.5厘米至25厘米之间。手术技术包括局部切除和广泛切除,部分患者进行了植皮或皮瓣修复。11例患者接受了辅助放射治疗,剂量为46至68 Gy(1例术前放疗,10例术后放疗)。中位随访时间为50个月(范围11至131个月),11例患者(9例未接受放疗)出现局部复发。所有复发患者均接受了挽救性治疗(再次切除,部分患者联合放疗),10例患者病情得到控制。部分患者存在与治疗相关的中度美容或功能问题。
隆突性皮肤纤维肉瘤是一种治愈率较高的恶性肿瘤,辅助放射治疗可可靠地降低局部复发率,防止因重复手术导致的毁容和功能缺陷。